Even when my liver enzymes weren’t in range when I cycled methylated orals like Dianabol and Superdrol several times years ago there was no difference in my androgenic alopecia progression. I had perfect Estrogen levels throughout the entirety of my Dutasteride experiment (and still do) – still experienced androgenic alopecia. If you crush your estrogen into the ground with Letrozole or another AI, you're inhibiting a critical hormone that facilitates healthy hair growth, but not causing androgenic alopecia itself. The mean fat-free mass gained by the placebo groups was 0.8 kg (95% CI, −0.1 to 1.7 kg) when receiving 50 mg/wk of testosterone enanthate, 3.5 kg (95% CI, 2.1 to 4.8 kg) for 125 mg/wk, 5.7 kg (95% CI, 4.8 to 6.5 kg) for 300 mg/wk, and 8.1 kg (95% CI, 6.7 to 9.5 kg) for 600 mg/wk. The mean fat-free mass gained by the dutasteride groups was 0.6 kg (95% CI, −0.1 to 1.2 kg) when receiving 50 mg/wk of testosterone enanthate, 2.6 kg (95% CI, 0.9 to 4.3 kg) for 125 mg/wk, 5.8 kg (95% CI, 4.8 to 6.9 kg) for 300 mg/wk, and 7.1 kg (95% CI, 6.0 to 8.2 kg) for 600 mg/wk. The 5α-Reductase Trial was a randomized controlled trial of healthy men aged 18 to 50 years comparing placebo plus testosterone enthanate with dutasteride plus testosterone enanthate from May 2005 through June 2010. Clinically significant interactions with dutasteride are not known. However, the rate of undifferentiated prostate carcinoma was higher in the verum group without an effect on overall survival (Goodman et al., 2019). Furthermore, the function of 5α-reductase on other steroids is poorly understood. Part of the study was done at the Clinical Research Center, University of Washington and the General Clinical Research Center, Harbor-UCLA Medical Center. Marilyn Busher, Kathy Winter and Kathryn Torrez Duncan assisted with study clinical aspects. Concomitant dutasteride did not reduce the effect of testosterone replacement therapy in men with late-2onset hypogonadism. Secondary outcomes were the post-treatment IPSS, peak urinary flow rate, post-void residual urine volume (PVR), and prostate volume. The primary outcomes were the change in the aging male symptom (AMS) score, sexual desire (question 17, AMS score), and erectile function (International Index of Erectile Function-5). We examined whether concomitant dutasteride reduced the efficacy of testosterone replacement therapy (TRT) in men with late-onset hypogonadism. Oral T administration in this study did not cause liver inflammation and most adverse events were minor. To our knowledge whether additional increases in metabolism would continue with longer treatment is unknown but for some medications this effect stabilizes with time. A drawback to our study was the relatively few men per group, the number who did not complete the study, and the lack of homogeneity in age and baseline T. Thus, future studies will focus on formulations with modified release characteristics for dose optimization to maintain Tavg in the normal range and maximum T below a reasonable level. There were no significant changes in hemoglobin and blood counts, serum chemistry, or markers of liver inflammation or PSA (data not shown). There were 16 nonserious adverse events without evidence of clustering to a specific treatment, of which the most common were headache, dizziness, upper respiratory infection, vomiting, back pain and frequent urination in 2 men each. While SARMs have been examined in preclinical rodent models in the context of their efficacy profiles for managing benign prostate hyperplasia, the effect they have on endogenous anabolic and androgenic activity can be reverse engineered to see its blatant potential in hair loss prevention R. I already know I’m severely prone to hair loss at that dosage with no protection, and I had to test the true extent of Testosterone’s own androgenic activity with DHT totally taken care of to know for sure what was going on in the body and to confirm my suspicions. I used to think they were the devil but I started to research more and realize what the androgenic component of certain anabolics really accomplishes in the body and how it really plays out in the whole cascade of events leading to eventual hair loss progression. In general, the more androgenic a hormone is, the more it will increase prostate size and cause hair loss.
